Status:
UNKNOWN
Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai
Lead Sponsor:
Ruijin Hospital
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
This study is to clarify the clinical characteristics of severe and critical COVID-19 from March 1st ,2022 to June 9th, 2022 in Shanghai and to explore the relationship between the characteristics and...
Detailed Description
1. To Describe the clinical characteristics of severe and critical COVID-19. 2. To analyze the relationship between the clinical characteristics and their clinical prognosis; 3. To analyze the relatio...
Eligibility Criteria
Inclusion
- severe and critical covid-19 patients who met the "Diagnosis and Treatment Plan for new Coronavirus Pneumonia (Ninth Edition)"
- admission time more than 24 hours
Exclusion
- admission time less than 24 hours
Key Trial Info
Start Date :
June 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 10 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05422963
Start Date
June 10 2022
End Date
June 10 2023
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital
Shanghai, China